Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha CognitionACOG -0.45%35 Price-to-Tangible-Book is 4.16 as of Sep. 22, 2026. GuruFocus rates ACOG with a GF Score™ of 35/100. The stock has 5 warning signs investors should review. Among 1,133 Biotechnology companies, Alpha Cognition ranks worse than 59.66% on this metric.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Alpha Cognition Price-to-Tangible-Book Related Terms
Alpha Cognition Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Alpha Cognition's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACOG vs NKTX, ARMP, CUE: Price-to-Tangible-Book Comparison
For the Biotechnology subindustry, Alpha Cognition's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Cognition Price-to-Tangible-Book vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alpha Cognition's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Alpha Cognition's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Alpha Cognition (ACOG) has a Price-to-Tangible-Book of 4.16 as of Sep. 22, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Alpha Cognition and its competitors. According to the industry distribution chart, Alpha Cognition ranks #676 out of 1133 companies in the Biotechnology industry, placing it in the top 59.7%.
Is Alpha Cognition's Price-to-Tangible-Book too high?
Alpha Cognition's current Price-to-Tangible-Book is 4.16. The Biotechnology industry median Price-to-Tangible-Book is 3.31. Alpha Cognition's value of 4.16 is 25.7% above this industry median. Based on the distribution chart, Alpha Cognition ranks #676 out of 1133 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alpha Cognition has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Price-to-Tangible-Book compare to NKTX and ARMP?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #676 out of 1133 companies for Price-to-Tangible-Book. This places Alpha Cognition in the lower half of its industry. The industry median Price-to-Tangible-Book is 3.31. Alpha Cognition's value of 4.16 is 25.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Biotechnology company?
The median Price-to-Tangible-Book among Biotechnology companies is 3.31, based on 1,133 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Cognition's current Price-to-Tangible-Book of 4.16 is 25.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Alpha Cognition and its competitors. For the Biotechnology industry, the median Price-to-Tangible-Book is 3.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Cognition's current Price-to-Tangible-Book is 4.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Price-to-Tangible-Book of 4.16. The current Price-to-Tangible-Book is 4.16 and 25.7% above the Biotechnology industry median of 3.31. Alpha Cognition's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Price-to-Tangible-Book is 4.16 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
35GF Score
Get the complete analysis for ACOG
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACOG has been successfully added to your 
